Ectopic Adipose Tissue Depots and Metabolic-Associated Fatty Liver Disease: Relationships With Vitamin D
- 1Department of Faculty Therapy No. 2, I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia
- 2Department of Infectious Diseases, I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia
Abstract
Background: The relationship between vitamin D status, adipose tissue dysfunction and the development of metabolic-associated fatty liver disease (MAFLD) is currently under active investigation. This study aimed to assess the associations of serum vitamin D levels with MAFLD and different ectopic adipose tissue depots, including perivascular adipose tissue (PVAT), epicardial adipose tissue (EAT), and hepatic steatosis, and to determine whether these associations persisted after adjustment for potential confounders.
Methods: This cross-sectional study included 303 patients without established atherosclerotic cardiovascular disease (mean age 55 years (40–60)). PVAT was evaluated by measuring the common carotid artery extra-media thickness (CCA EMT) using duplex ultrasound. EAT thickness was assessed by echocardiography. Hepatic steatosis was quantified by measuring the attenuation coefficient (AC) using vibration-controlled transient elastography. Serum 25-OH vitamin D levels were determined using enzyme-linked immunosorbent assay. Patients were stratified into four groups according to serum vitamin D levels. Multivariable logistic and linear regression analyses were performed to account for potential confounders.
Results: Hepatic steatosis was detected in 125 (41.3%) patients, and MAFLD was detected in 110 (36.3%). Significant inverse correlations were observed between vitamin D levels and AC (r = −0.238) and MAFLD (r = −0.242) (both P < 0.05). General and abdominal obesity were significantly more prevalent in patients with severe vitamin D deficiency compared with those with vitamin D insufficiency and target levels (50% vs. 26.8% and 23%; 70% vs. 29.3% and 23.1%, respectively; P = 0.001 for both). MAFLD was also significantly more frequent in the severe deficiency group than in the deficiency, insufficiency, and target level groups (80% vs. 31.3%, 34.1%, and 15.4%; P = 0.001). In adjusted analyses, the association between 25(OH)D and MAFLD was attenuated after adjustment for body mass index but remained significant in the model including waist circumference. Compared with patients with target vitamin D levels, those with severe deficiency exhibited greater EAT thickness, CCA EMT, and AC (all P < 0.05). Higher 25(OH)D concentrations were independently associated with lower CCA EMT, AC, and EAT thickness after adjustment for age, sex, and adiposity.
Conclusion: Our findings demonstrate associations between vitamin D deficiency, ectopic adipose tissue depots, and MAFLD, suggesting that low vitamin D levels may potentially be linked to adipose tissue dysfunction and cardiometabolic remodeling.
Related
- Adipose Tissue Pericellular Fibrosis, Weight Loss and Features of Metabolic Dysfunction-Associated Steatotic Liver Disease after Bariatric Surgery
- The Platelet–Adipose Tissue Axis in Metabolic Disease: From Platelet Reprogramming to Tissue Remodeling
- Lactate Drives Pathological Browning of White Adipose Tissue to Aggravate Sepsis-Associated Metabolic Disorders in a GPR81-Dependent Manner.
- Single-cell landscape of human adipose tissue reveals THBS1 as a potential driver of fibro-inflammation in metabolic disease
- MRI-based proton density fat fraction combined with adipose tissue for identifying metabolic dysfunction-associated steatohepatitis
BibTeX
@article{bragina2026ectopic,
title = {{Ectopic Adipose Tissue Depots and Metabolic-Associated Fatty Liver Disease: Relationships With Vitamin D}},
author = {Anna Bragina and Yulia Rodionova and Maria Vetluzhskaya and Maria Vasilchenko and Irakli Loriya and Daria Akvitskaya and Sarvar Abduganiev and Olga Belaya and Karina Umbetova and Andrey Gorobchenko and Danila Voevodin and Valeriy Podzolkov},
journal = {Journal of Clinical Medicine Research},
year = {2026},
month = oct,
doi = {10.14740/jocmr6709},
url = {https://europepmc.org/article/PMC/PMC13719649},
note = {CC BY},
}
RIS
TY - JOUR
TI - Ectopic Adipose Tissue Depots and Metabolic-Associated Fatty Liver Disease: Relationships With Vitamin D
AU - Anna Bragina
AU - Yulia Rodionova
AU - Maria Vetluzhskaya
AU - Maria Vasilchenko
AU - Irakli Loriya
AU - Daria Akvitskaya
AU - Sarvar Abduganiev
AU - Olga Belaya
AU - Karina Umbetova
AU - Andrey Gorobchenko
AU - Danila Voevodin
AU - Valeriy Podzolkov
PY - 2026
DA - 2026/10/01
JO - Journal of Clinical Medicine Research
DO - 10.14740/jocmr6709
UR - https://europepmc.org/article/PMC/PMC13719649
AB - Background: The relationship between vitamin D status, adipose tissue dysfunction and the development of metabolic-associated fatty liver disease (MAFLD) is currently under active investigation. This study aimed to assess the associations of serum vitamin D levels with MAFLD and different ectopic adipose tissue depots, including perivascular adipose tissue (PVAT), epicardial adipose tissue (EAT), and hepatic steatosis, and to determine whether these associations persisted after adjustment for potential confounders. Methods: This cross-sectional study included 303 patients without established atherosclerotic cardiovascular disease (mean age 55 years (40–60)). PVAT was evaluated by measuring the common carotid artery extra-media thickness (CCA EMT) using duplex ultrasound. EAT thickness was assessed by echocardiography. Hepatic steatosis was quantified by measuring the attenuation coefficient (AC) using vibration-controlled transient elastography. Serum 25-OH vitamin D levels were determined using enzyme-linked immunosorbent assay. Patients were stratified into four groups according to serum vitamin D levels. Multivariable logistic and linear regression analyses were performed to account for potential confounders. Results: Hepatic steatosis was detected in 125 (41.3%) patients, and MAFLD was detected in 110 (36.3%). Significant inverse correlations were observed between vitamin D levels and AC (r = −0.238) and MAFLD (r = −0.242) (both P < 0.05). General and abdominal obesity were significantly more prevalent in patients with severe vitamin D deficiency compared with those with vitamin D insufficiency and target levels (50% vs. 26.8% and 23%; 70% vs. 29.3% and 23.1%, respectively; P = 0.001 for both). MAFLD was also significantly more frequent in the severe deficiency group than in the deficiency, insufficiency, and target level groups (80% vs. 31.3%, 34.1%, and 15.4%; P = 0.001). In adjusted analyses, the association between 25(OH)D and MAFLD was attenuated after adjustment for body mass index but remained significant in the model including waist circumference. Compared with patients with target vitamin D levels, those with severe deficiency exhibited greater EAT thickness, CCA EMT, and AC (all P < 0.05). Higher 25(OH)D concentrations were independently associated with lower CCA EMT, AC, and EAT thickness after adjustment for age, sex, and adiposity. Conclusion: Our findings demonstrate associations between vitamin D deficiency, ectopic adipose tissue depots, and MAFLD, suggesting that low vitamin D levels may potentially be linked to adipose tissue dysfunction and cardiometabolic remodeling.
SN - 1918-3003
SN - 1918-3011
ER -